Xanthone derivatives
Abstract
Abstract XANTHORNE DERIVATIVES OF THE FORMULA: 2-X,9-(O=),R1,R2-XANTHENE IN WHICH X REPRESENTS A CARBOXYL OR 5-(1H)-TETRAZOLYL GROUP; AND R1 AND RI WHICH MAY BE THE SAME OR DIFFERENT EACH REPRESENT A HYDROGEN ATOM, AN ALKYL GROUP CONTAINING FROM 1 TO 4 CARBON ATOMS, A NITRO GROUP, A HALOGEN ATOM OR A GROUP OF THE FORMULA-NR3R4 OR OR3 OR NR5SO2R6 (IN WHICH THE GROUPS R2 AND R4 WHICH MAY BE THE SAME OR DIFFERENT EACH REPRESENT A HYDROGEN ATOM, A PHENYL GROUP, A BENZYL GROUP OR AN ALKYL GROUP WHICH MAY OPTIONALLY BE SUBSTITUTED BY AN ALKOXY GROUP CONTAINING FROM 1 TO 6 CARBON ATOMS, A PHENOXY GROUP, PHENYL GROUP, AN AMINO, ALKYLAMINO OR DIALKYLAMINO GROUP OR BY ONE OR MORE HYDROXY GROUPS; AND IN WHICH R5 IS A HYDROGEN ATOM OR AN ALKYL GROUP CONTAINING FROM 1 TO 6 CARBON ATOMS AND R6 IS AN ALKYL GROUP CONTAINING FROM 1 TO 6 CARBON ATOMS); WITH THE PROVISO THAT WHEN X REPRESENTS A CARBOXYL GROUP R1 AND R2 DO NOT BOTH REPRESENT HYDROGEN ATOMS; AND PHARMACEUTICALLY ACCEPTABLE NON-TONIX SALTS AND ESTERS OF SUCH COMPOUNDS. THESE DERIVATIVES HAVE PHARMACOLOGICAL ACTIVITY AND IT PARTICULAR INHIBIT THE RELEASE OF SPASMOGEN MEDIATORS FROM ANTIGEN-ANTIBODY REACTIONS.
Inventors
- 👤 David Edmund Bays
Bibliographic Details
Claims Analysis
Total Claims: 0References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1975-12-19 | 1976-06-19 | 1976-12-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1979-12-19 | 1980-06-19 | 1980-12-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1983-12-19 | 1984-06-19 | 1984-12-19 | $7700.00 | Window Closed / Lapsed |